Peripherally-driven myeloid NFkB and IFN/ISG responses predict malignancy risk, survival, and immunotherapy regime in ovarian cancer
====================================================================================================================================

* Jenny Sprooten
* Ann Vankerckhoven
* Isaure Vanmeerbeek
* Daniel M Borras
* Yani Berckmans
* Roxanne Wouters
* Raquel S Laureano
* Thais Baert
* Louis Boon
* Chiara Landolfo
* Antonia Carla Testa
* Daniela Fischerova
* Caroline Van Holsbeke
* Tom Bourne
* Valentina Chiappa
* Wouter Froyman
* Dominique Schols
* Patrizia Agostinis
* Dirk Timmerman
* Sabine Tejpar
* Ignace Vergote
* An Coosemans
* Abhishek D Garg